EP
OTIC

Eversept Partners’s Otonomy, Inc. OTIC Stock Holding History

Eversept Partners’s Portfolio OTIC Stock Details OTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-198,400
Closed -$506M – 111
2021
Q1 		$506M Buy
+198,400
New +$813K 26.21% 1

Other funds holding OTIC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Eversept Partners's OTIC Position: Q1 2021 in Review

Eversept Partners sold out of Otonomy, Inc. (OTIC) in Q1 2021, closing a stake of 253,283 shares — an estimated $1.04M sold.

Eversept Partners first reported a position in OTIC in Q1 2019 and held it in 8 quarters. The position peaked at $2.18M in Q2 2020. 62 funds tracked by Wall St. Rank hold OTIC as of Q1 2021.

  • Eversept Partners reported no remaining Otonomy, Inc. position as of Q1 2021 after selling out during the quarter.
  • Eversept Partners sold 253,283 Otonomy, Inc. shares in Q1 2021, an estimated $1.04M.
  • Eversept Partners first reported a position in Otonomy, Inc. in Q1 2019 and held it in 8 quarters.
  • Eversept Partners's Otonomy, Inc. position peaked at $2.18M in Q2 2020.
  • 62 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q1 2021.

Based on Eversept Partners's 13F filing for Q1 2021, filed 13 May 2021.